Toxic epidermal necrolysis associated with pembrolizumab.
Cai ZR, Lecours J, Adam JP, Marcil I, Blais N, Dallaire M, Belisle A, Mathieu A.
Cai ZR, et al. Among authors: belisle a.
J Oncol Pharm Pract. 2020 Jul;26(5):1259-1265. doi: 10.1177/1078155219890659. Epub 2019 Dec 6.
J Oncol Pharm Pract. 2020.
PMID: 31810421